Mode
Text Size
Log in / Sign up

LEARNS model-based health education improves Health Education Scale scores in stable pneumoconiosis patients.

LEARNS model-based health education improves Health Education Scale scores in stable pneumoconiosis …
Photo by ‪Salah Darwish / Unsplash
Key Takeaway
Consider LEARNS model-based health education plus conventional treatment for stable pneumoconiosis to improve health education scores.

This randomized controlled trial enrolled 120 patients with stable pneumoconiosis, divided into an intervention group (n = 60) and a control group (n = 60). The intervention group received the LEARNS model-based health education delivered three times weekly for 12 weeks plus conventional treatment, whereas the control group received conventional treatment alone. Assessments were conducted at baseline (T0), 4 weeks (T4), 8 weeks (T8), and 12 weeks (T12). Secondary outcomes included 6-min walking distance, modified Medical Research Council dyspnea scale, and disease-specific symptom dimensions.

Primary results focused on Health Education Scale scores. In the intervention group, scores increased from 80.20 ± 11.74 at baseline to 110.89 ± 8.76 at 12 weeks. In contrast, the control group showed an improvement of 5.89 points versus 30.69 points in the intervention group. The adjusted mean difference was +11.32 at T4, +15.87 at T8, and +18.97 at T12. Statistical analysis yielded F = 100.355, p < 0.001, with Padjusted < 0.001 for the intervention and Padjusted = 0.181 for the control.

Safety and tolerability data, including adverse events, serious adverse events, discontinuations, and general tolerability, were not reported. The study design supports causal inference regarding the educational intervention's effect on health education scores. While the structured educational approach offers a promising strategy for comprehensive pneumoconiosis management, the lack of reported safety data limits the ability to assess the full risk-benefit profile of this intervention.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
ObjectivesTo evaluate the effect of LEARNS model-based health education for patients with pneumoconiosis.Study designA randomized controlled trial with repeated measures design was conducted. A total of 120 patients with stable pneumoconiosis were randomly assigned to either a control group (n = 60) receiving conventional treatment or an intervention group (n = 60) receiving conventional treatment plus LEARNS model-based health education.MethodsThe health education intervention was delivered three times weekly for 12 weeks. Primary outcomes were measured using the Health Education Scale at baseline (T0), 4 weeks (T4), 8 weeks (T8), and 12 weeks (T12). Secondary outcomes included the 6-min walking distance (6MWD), modified Medical Research Council (mMRC) dyspnea scale, and disease-specific symptom dimensions. Data were analyzed using the intention-to-treat (ITT) principle.ResultsThe intervention group demonstrated significant improvements in health education scale scores compared to the control group (F = 100.355, p < 0.001). Scores increased from 80.20 ± 11.74 at baseline to 110.89 ± 8.76 at 12 weeks in the intervention group, representing a 30.69-point improvement (Padjusted < 0.001), vs. only 5.89-point improvement in the control group (Padjusted = 0.181). Between-group differences became statistically significant from T4 onwards, with adjusted mean difference of +11.32, +15.87, +18.97, respectively at T4, T8, and T12 compared with the control after baseline unbalanced variables adjusted.ConclusionsLEARNS model-based health education significantly improves health literacy and self-management capabilities in patients with pneumoconiosis. The intervention demonstrates cumulative effects over time and substantial clinical significance. This structured educational approach offers a promising strategy for comprehensive pneumoconiosis management.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.